To export cosmetics to the USA compliantly under MoCRA, work through this checklist before your goods ship: confirm each product is legally a cosmetic, register the manufacturing facility with the FDA, list every product, hold safety substantiation, appoint a US agent for the overseas facility and a responsible person for the brand, label in English with an adverse-event contact, and keep manufacturing and testing documentation ready for import entry. None of these steps is an FDA "approval" — the FDA does not approve cosmetics — but each one is mandatory, and the responsibility for completing them sits with the brand and its supply chain.
☐ Step 1: Confirm each product is a cosmetic, not a drug
US law decides what a product is by its intended use and claims, not by its formula alone. Appearance-based claims — cleanses, moisturises, helps skin look firmer, reduces the appearance of fine lines or dark spots — keep a product in cosmetic territory. Claims to treat, cure or change the structure or function of the body push it towards drug regulation, and some familiar categories are drugs in the US even though they are cosmetics elsewhere: sunscreens are the classic example. Review every claim first, because a drug classification changes the entire compliance route.
☐ Step 2: Register the manufacturing facility
Every facility that manufactures or processes cosmetics for the US market must be registered with the FDA, and the registration kept current. The facility is identified in FDA systems by its FEI number. If you buy from an overseas factory, confirm how its registration is handled, and ask for details of the actual facility making your products. Registration is a listing on record, not an FDA approval or endorsement.
☐ Step 3: List every product
Each cosmetic product marketed in the US must be listed with the FDA by the responsible person, identifying the product and the facility where it is made. Agree with your manufacturer who supplies the data, who submits, and who maintains the listings.
☐ Step 4: Hold safety substantiation
MoCRA requires adequate substantiation of safety for every product, held as records by the responsible person. In practice this means documented support for the formula as sold: ingredient safety screening against US rules, microbiological and stability testing, plus sterility testing for sterile-filled formats and patch testing where relevant. Assemble this file before launch, not after a retailer or marketplace asks for it.
☐ Step 5: Get the label right
US cosmetic labels must be in English and carry: the product's identity, the net quantity of contents, a complete ingredient list using accepted INCI names, the name and place of business of the responsible person, and any necessary warnings. MoCRA additionally requires a domestic address, phone number or electronic contact on the label through which the responsible person can receive adverse-event reports. Professional products should also be labelled so their cosmetic, non-injectable status is unmistakable.
☐ Step 6: Appoint a US agent and confirm the responsible person
A facility outside the US must designate a US agent to act as its contact point for FDA communications. Every product also needs a responsible person: the party named on the label, who carries the MoCRA duties for listing, safety records and adverse events. If you import under your own brand, expect to be the responsible person yourself, with your manufacturer supporting you with data. Document both appointments before production.
☐ Step 7: Prepare manufacturing and testing documentation
Hold the documentation that buyers, marketplaces and customs may request: evidence of good manufacturing practice at the factory (our own production is organised under ISO 22716, ISO 9001 and China NMPA Cosmetics GMP), a certificate of analysis (COA) for each batch, a material safety data sheet (MSDS), stability results, and batch traceability records. The structure behind these documents is described on our quality and contract manufacturing pages. Halal certification is available on request for markets that require it.
☐ Step 8: Plan for adverse events and records
Compliance continues after the products land. The responsible person must keep adverse-event records, report serious adverse events to the FDA within the required framework, and keep records current as products change. Set up the intake route — the label contact from Step 5 — and an internal log before the first shipment.
☐ Step 9: Prepare for import entry
Finally: accurate commercial documents identifying the products and manufacturer, the Steps 2–7 documentation on request, and a customs broker who knows the category. The FDA reviews imported cosmetics at entry and can examine or refuse goods that appear non-compliant, so the file you built for MoCRA is also your import file. If you are preparing a US launch and want a manufacturer who supports these steps with documentation, talk to us.
Preguntas frecuentes
Does the FDA approve cosmetics imported into the USA? No. Apart from colour additives, cosmetics do not receive FDA pre-market approval. MoCRA compliance — facility registration, product listing, safety substantiation and correct labelling — is the brand's responsibility to complete and to evidence.
Are sunscreens treated as cosmetics in the USA? No. Sunscreens are regulated as over-the-counter drugs in the US, with a different registration, listing and labelling route. The same applies to some other categories that are ordinary cosmetics in other markets, which is why the category check is Step 1.
What is a US agent, and who needs one? A US agent is a person or company based in the United States who acts as the FDA's contact point for a facility located abroad. Every overseas cosmetic facility supplying the US market needs one; the role covers FDA communication only.
Which documents should I hold before the first shipment? Facility registration details, product listing confirmation, your safety substantiation file, English labelling, per-batch documentation (COA, MSDS, traceability records) and your adverse-event procedure.